U.S. CDC advisers to meet this month to discuss Moderna, J&J COVID-19

(Reuters) – The U.S. Centers for Disease Control and Prevention’s panel of vaccine advisers plans to meet on Oct. 20-21 to discuss COVID-19 vaccine boosters using Moderna (NASDAQ:) and Johnson & Johnson (NYSE:) shots, an agency spokesperson said on Friday.

The CDC’s Advisory Committee on Immunization Practices will meet on Nov. 2-3 to discuss COVID-19 vaccination for children.

The agendas for the meetings will be posted closer to the meeting dates, the spokesperson said.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.